Results from METIS (EF-25), an international, multicenter phase III randomized study evaluating the efficacy and safety of tumor treating fields (TTFields) therapy in NSCLC patients with brain metastases. Article

Mehta, Minesh P, Gondi, Vinai, Ahluwalia, Manmeet Singh et al. (2024). Results from METIS (EF-25), an international, multicenter phase III randomized study evaluating the efficacy and safety of tumor treating fields (TTFields) therapy in NSCLC patients with brain metastases. . JOURNAL OF CLINICAL ONCOLOGY, 42(16_suppl), 2008-2008. 10.1200/jco.2024.42.16_suppl.2008

cited authors

  • Mehta, Minesh P; Gondi, Vinai; Ahluwalia, Manmeet Singh; Roberge, David; Ilic, Rosanda; Sio, Terence Tai Weng; Trifiletti, Daniel Michael; Muanza, Thierry; Krpan, Ana Misir; Ramakrishna, Naren R; Fiveash, John B; Metellus, Philippe; Wang, Chiachien Jake; Feuvret, Loïc; Freyschlag, Christian; Csőszi, Tibor; Brown, Paul D; Zhu, Zhengfei; Yu, Jinming; Harat, Maciej

authors

publication date

  • June 1, 2024

published in

keywords

  • 3 Good Health and Well Being
  • 32 Biomedical and Clinical Sciences
  • 3211 Oncology and Carcinogenesis
  • 6.1 Pharmaceuticals
  • 7.1 Individual care needs
  • Behavioral and Social Science
  • Brain Cancer
  • Brain Disorders
  • Cancer
  • Clinical Research
  • Clinical Trials and Supportive Activities
  • Lung
  • Lung Cancer
  • Minority Health
  • Neurosciences
  • Radiation Oncology
  • Rare Diseases

Digital Object Identifier (DOI)

publisher

  • American Society of Clinical Oncology (ASCO)

start page

  • 2008

end page

  • 2008

volume

  • 42

issue

  • 16_suppl